VistaGen Therapeutics, Inc. (VTGN) Social Stream
VistaGen Therapeutics Inc (VTGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering VistaGen Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
VTGN's average price target has moved up $1 over the prior 26 weeks.
VTGN reports an average of 158.25% for its upside potential over the past 44 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VTGN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
VTGN's average broker recommendation rating improved by 0.5 over the prior 39 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, VistaGen Therapeutics Inc's upside potential (average analyst target price relative to current price) is greater than 193.01% of them.
- In the context of all US stocks, VistaGen Therapeutics Inc's number of analysts covering the stock is greater than 9.42% of them.
- In terms of how VistaGen Therapeutics Inc fares relative to all US stocks, note that its average analyst price target is greater than 10.98% of that group.
- In the context of stocks in the small market cap category, VistaGen Therapeutics Inc's variance in analysts' estimates is lower than 37.33% of them.
Make investment decisions regarding VTGN using the data that counts. Try POWR Ratings for free.